Skip to main content
BLUGLASS LIMITED logo

BLUGLASS LIMITED - Investor Relations & Filings

Listed IPO Sep 2006
Ticker · BLG ISIN · AU000000BLG5 LEI · 529900R2JHAK63RQH645 ASX Manufacturing
Filings indexed 1,167 across all filing types
Latest filing 2026-07-16 Regulatory Filings
Country AU Australia
Listing ASX BLG · 1 venue

Key figures FY2025

Period ended 2025-06-30 · AUD
Headline annual figures for BLUGLASS LIMITED, fiscal year 2025, reported in AUD, with the source filing for each figure.
Total Revenues AUD 5.45M per the Annual Report filed 2025-08-26
Net Income AUD -10.98M per the Annual Report filed 2025-08-26
Total Assets AUD 23.93M per the Annual Report filed 2025-08-26
Total Equity AUD 11.59M per the Annual Report filed 2025-08-26
Cash from Ops AUD -6.15M per the Annual Report filed 2025-08-26

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About BLUGLASS LIMITED

https://bluglass.com/

BluGlass Limited specializes in the development and manufacture of high-performance semiconductor devices, specifically focusing on Gallium Nitride (GaN) laser diodes. The company utilizes its proprietary Remote Plasma Chemical Vapour Deposition (RPCVD) technology, which enables the growth of semiconductor layers at lower temperatures than conventional methods. This process is designed to enhance device performance, improve electrical efficiency, and offer greater manufacturing flexibility. BluGlass provides a range of laser diode products across the violet, blue, and green spectrums, targeting applications in industrial processing, medical diagnostics, quantum computing, and high-brightness displays. By leveraging its unique deposition technology, the company aims to address the technical limitations of traditional Metal-Organic Chemical Vapour Deposition (MOCVD) in the production of optoelectronic components.

Recent filings

Filing Released Lang Actions
BluGlass secures A$1.4 mil Phase II contract from Uviquity 2 pages 347.1KB
Regulatory Filings Classification · 95% confidence The document is a corporate announcement regarding a new business contract (Phase II of a Joint Development Agreement) between BluGlass and Uviquity. It details the nature of the partnership, the financial value (A$1.4 million), and the strategic implications. It does not fit into financial reporting categories like 10-K or IR, nor is it a dividend or share transaction notice. As it is a general regulatory announcement regarding business operations and contracts, it falls under the RNS (Regulatory Filings) category.
2026-07-16 English
Jim Haden appointed as Managing Director 1 page 289.3KB
Board/Management Information Classification · 100% confidence The document is a corporate announcement regarding the appointment of Jim Haden as Managing Director of BluGlass. It details his transition from Executive Director to Managing Director while maintaining his role as CEO. This falls squarely under the definition of an announcement of changes in the company's board of directors or senior management.
2026-07-13 English
Notification of cessation of securities - BLG 4 pages 14.8KB
Regulatory Filings Classification · 95% confidence The document is an 'Appendix 3H' filing submitted to the ASX, which is a standard regulatory form used to notify the market of the cessation of securities (in this case, the lapse of performance rights). This type of filing relates to changes in the company's capital structure and issued securities. Since it does not fit into specific categories like 'Share Issue/Capital Change' (which typically refers to new issuances) or 'Transaction in Own Shares' (buybacks), and it is a formal regulatory notification required by the exchange, it is best classified as a Regulatory Filing (RNS).
2026-07-10 English
Change of Directors' Interest Notices 9 pages 591.5KB
Director's Dealing Classification · 100% confidence The document is an 'Appendix 3Y' form, which is the standard ASX regulatory filing for a 'Change of Director's Interest Notice'. It details specific share and option acquisitions by company directors (Omer Granit, Ata Gokyildirim, and Jim Haden). This falls directly under the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2026-06-22 English
Application for quotation of securities - BLG 6 pages 18.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an 'Appendix 2A' filing from the Australian Securities Exchange (ASX), which is the standard form used by companies to apply for the quotation of new securities following the exercise of options or conversion of convertible securities. This falls under the category of share issuance and capital changes. While it involves a change in capital, it is specifically an application for quotation of securities, which aligns best with the 'Share Issue/Capital Change' (SHA) category.
2026-06-16 English
Notification regarding unquoted securities - BLG 5 pages 16.8KB
Regulatory Filings Classification · 95% confidence The document is an 'Appendix 3G' filing from the Australian Securities Exchange (ASX), which is a standard regulatory form used to notify the market of the issue, conversion, or payment of unquoted equity securities. While it involves the issuance of options, it is a formal regulatory notification required by the ASX listing rules rather than a discretionary capital raising announcement or a share buyback (POS). Since it is a specific regulatory disclosure form for securities issuance, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback for ASX-specific regulatory forms that do not fit into the specific 'Share Issue' (SHA) category (which typically refers to broader capital changes or public share issues).
2026-06-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.